ISOPTO CARPINE Rx
Generic Name and Formulations:
Pilocarpine HCl 1%, 2%, 4%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for ISOPTO CARPINE:
2 drops up to 3–4 times daily or more if needed. Heavily pigmented irides may require higher concentrations.
When constriction is undesirable (e.g., acute iritis). Pupillary block glaucoma.
History or risk of retinal detachment. Asthma. Bradycardia. Hypotension. Pregnancy (Cat.C). Nursing mothers.
Local irritation, ciliary spasm, conjunctival injection, headache, induced myopia, Transient night blindness may occur (esp. in elderly or lens opacities). Retinal detachment, lens opacity (rare). Systemic cholinergic effects (excessive absorption).
1%, 2%, 4%—15mL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Nicotinamide and Cancer
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- Opioid Prescription Protocol Decreases Opioid Use After Gynecologic Surgery
- Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma
- Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML